#41: South Korea’s got it all: Beach Yoga, Sunsets, and Oops — Ketamine Tea Bags

• 🤖 Meet MT-GBM: Korean AI that predicts post-surgery complications - kidney shocks, breathing trouble, even death in real time, while patients remain under anesthesia! (MobiHealthNews)

• 🦷 Tooth-tally amazing! Japanese scientists developed a calcium-based gel that helps teeth self-repair by regrowing enamel and preventing cavities, no drills needed. (TOI)

• 🚨 Stanford built OrganMate AI that scans donor vitals to predict when a liver will be retrieval-ready, cutting cancelled transplants by 60%. (TheGuardian)

• ☕ One cup of coffee a day may trim the risk of irregular heartbeat episodes by 39%, thanks to caffeine’s quirky heart-protecting powers. (MNT)

• 🔥 Fat’s got your back: Japanese scientists convert stem cells from body fat into bone, opening a path to heal spinal fractures. (ETHealth)

• 🚀 Weight-loss showdown: Novo Nordisk and Emcure Pharma launch Wegovy as Poviztra in India, a rebrand to boost reach amid soaring demand. (IndiaToday)

• ✅ The affordable headache hero! Alembic Pharma scores the U.S. FDA nod for its generic injection to treat acute migraine pain. (ET)

• 💉 Zydus Lifesciences scores the U.S. FDA approval for its generic prostate cancer injection, entering a market worth over $880M. (ET)

🇮🇳 India

• 🩺 Ethics in freefall: NMC expels 4 doctors tied to the 10th November Red Fort blast, cancelling their state registrations on the spot. (IndianExpress)

• 🫁 Smog & sugar alert: Delhi’s toxic air may be spiking blood sugar by triggering inflammation and insulin resistance, raising diabetes risk. (FE)

• 🐾 India plans a ₹383 Cr ‘One Health’ mission to tackle zoonotic diseases, because 75% of new human illnesses have furry (or feathered) origins! (ETHealth)

🌏️ Global

• 🚨South Korea alert: Jeju’s beaches are hosting “tea” parties, except the tea is ketamine. 28 kg washed ashore in 2 months as smugglers turn the sea into a drug highway. (BBC)

• 🇺🇲 Sick note to visa? The U.S. may deny residency visas to Indians with chronic diseases, worried about healthcare costs and welfare dependancies. (ETHealth)

• ⚠️ Formula alert! FDA is probing a contamination scare after infant paralysis disorder cases emerged, leading to a baby formula recall.  (CNN)

• 👋🏻 Goodbye ‘black box’ warning! The U.S. FDA drops its strictest label on menopause hormone therapy, citing new evidence stating the treatments are safe. (CNN)

• 🦠 Remember our measles warning? It’s now official, Canada’s outbreaks and low vaccination rates have toppled its elimination status. (Reuters)

🇮🇳 India

• 💊 Wegovy’s on a diet too! Novo slashed its India price by up to 33%, monthly doses now start at ₹10,850. A move to stay competitive and widen patient access. (Reuters)

🌏️ Global

• 📈 Pfizer nabbed $10B Metsera bid over Novo last week, yet Novo Nordisk shares jump 2.9%, what a pharma plot twist! (Reuters)

• 🇨🇳 Cipla, Natco & Hetero Labs, India’s pharma heavyweights, land major contracts to supply key generics to China’s public hospitals. (ET)

• 💰 Merck is going all‑in on flu prevention, buying Cidara Therapeutics for $9.2B to get its hands on a once‑per‑season, long‑acting antiviral injectable. (Reuters)

📢 Enjoyed this edition?  Forward it to a friend or colleague who’d love to stay informed! They can subscribe here.